147 results
DEFA14A
SYRS
Syros Pharmaceuticals Inc.
23 Apr 24
Additional proxy soliciting materials
7:05am
of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024. 6. Approval, on a non
PRE 14A
SYRS
Syros Pharmaceuticals Inc.
12 Apr 24
Preliminary proxy
4:30pm
exculpation;
The ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending … Provisions Regarding Officer Exculpation
Proposal 5: Ratification of the Appointment of Ernst & Young LLP as our Independent Registered Public
S-8
SYRS
Syros Pharmaceuticals Inc.
27 Mar 24
Registration of securities for employees
7:04am
and Dorr LLP (included in Exhibit 5.1).
Consent of Ernst & Young LLP, independent registered public accounting firm.
Power of attorney (included
S-8
EX-23.2
ay9yg6v1ais2ia
27 Mar 24
Registration of securities for employees
7:04am
8-K
EX-1.1
jve4ctv3l79h
19 Dec 23
Syros Announces Pricing of $45.0 million Underwritten Offering of Common Stock and Pre-Funded Warrants
4:59pm
424B5
2dn2pg5hnq 5zouc
19 Dec 23
Prospectus supplement for primary offering
4:53pm
8-K
a4hl9erx
2 Jun 23
Submission of Matters to a Vote of Security Holders
4:14pm
424B5
9q6dhuuopav yymqyow
1 May 23
Prospectus supplement for primary offering
4:06pm
DEFA14A
xqmk3 eqy
21 Apr 23
Additional proxy soliciting materials
7:03am